Please note that some translations using Google Translate may not be accurately represented and downloaded documents cannot be translated. Dana-Farber/Boston Children’s assumes no liability for inaccuracies that may result from using this third-party tool, which is for website translation and not clinical interactions. You may request a medical interpreter for a discussion about your care.
Lisa Diller, MD named Innovator in Healthcare (Researcher) by Boston Business Journal
Lisa Diller, MD, Chief Medical Officer at the Dana-Farber/Boston Children’s Cancer and Blood Disorders Center, has been named an Innovator in Healthcare for Research by the Boston Business Journal. Dr. Diller is part of the inaugural class of healthcare professionals receiving this honor. Categories for the program include Chief Executive Leadership, Entrepreneur, Researcher, Health Equity Champion, Community Health, Nonprofit, and Advocacy.
The new program will “honor local professionals and entrepreneurs whose work stands out in the industry”. All honorees will be recognized in a special publication and will be celebrated at an event in February.
Congratulations to Dr. Diller for her achievement and for her lasting impact on Dana-Farber/Boston Children’s.